Big growth in biomaterials market (Health Care Finance News)
Ortho device companies expand to boost profits
NEW YORK – Advances in gene therapy and stem cell research are leading to double-digit annual sales growth in the orthopedic biomaterials market, according to the healthcare market research firm Kalorama Information.
In its recently published report, “Orthopedic Biomaterials, the World Market,” New York City-based Kalorama said biomaterials represent 14 percent of the global orthopedics market, or about $5.8 billion in 2010.
“Advances in gene therapy and stem cell research may offer new solutions for state-of-the-art treatments for musculoskeletal conditions,” said Bruce Carlson, publisher of Kalorama Information. “Many researchers believe that genetically engineered stem cells will have a significant impact on the fields of regenerative medicine and tissue engineering as a powerful cell source that will work, in conjunction with biomaterials, to treat tissue and bone loss.”
Musculoskeletal conditions are the most common cause of chronic disability. These conditions comprise over 150 diseases and syndromes, which are usually progressive and associated with pain. They c...
